Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)

Respiratory Medicine

Volumn 104, Issue 8, 2010, Pages 1160-1170

  Hanania, Nicola A ^a   Mannino, David M ^b   Yawn, Barbara P ^c   Mapel, Douglas W ^d   Martinez, Fernando J ^e   Donohue, James F ^f   Kosinski, Mark ^g   Rendas Baum, Regina ^g   Mintz, Matthew ^h   Samuels, Steven ⁱ   Jhingran, Priti ^j   Dalal, Anand A ^j  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c OLMSTED MEDICAL CENTER   (United States)

^d LOVELACE CLINIC FOUNDATION   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g QualityMetric Incorporated   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

ⁱ Indiana Internal Medicine Consultants   (United States)

^j GLAXOSMITHKLINE   (United States)

more..

Author keywords

Case finding tool; Chronic obstructive pulmonary disease; Health survey; Risk of obstruction; Screening tool; Spirometry

Indexed keywords

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTICLE; COUGHING; CROSS-SECTIONAL STUDY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETRY; VALIDITY; WHEEZING;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 77953962723     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.02.009     Document Type: Article

References (35)

1. Global initiative for chronic obstructive lung disease. Executive summary (2008), National Institutes of Health: National Heart, Lung, and Blood Institute. Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003 Updated
2. Radin A., and Cote C. Primary care of the patient with chronic obstructive pulmonary disease-part 1: frontline prevention and early diagnosis. Am J Med 121 Suppl. 7 (2008) S3-S12
3. Celli B.R. Chronic obstructive pulmonary disease: from unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc 3 (2006) 58-65
4. Celli B.R. Update on the management of COPD. Chest 133 (2008) 1451-1462
5. Cooper C.B., and Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease. Am J Med 121 Suppl. 7 (2008) S33-S45
6. Godtfredsen N.S., Lam T.H., Hansel T.T., et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 32 (2008) 844-853
7. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789
8. Ferguson G.T., Anzueto A., Fei R., et al. Effect of fluticasone propionate/salmeterol (250/50 mcg) or salmeterol (50 mcg) on COPD exacerbations. Respir Med 102 (2008) 1099-1108
9. Anzueto A., Ferguson G.T., Feldman G., et al. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. COPD (2009) 320-329
10. Vestbo J., Anderson W., Coxson H.O., et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE). Eur Respir J 31 (2008) 869-873
11. Lomas D.A., Silverman E.K., Edwards L.D., et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 63 (2008) 1058-1063
12. Lomas D.A., Silverman E.K., Edwards L.D., et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J (2009 Jan 22) [Epub ahead of print]
13. Decramer M., Celli B., Tashkin D.P., et al. Clinical trial design consideration sin assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD 1 (2004) 303-312
14. Mannino D.M., Gagnon R.C., Petty T.L., and Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160 (2000) 1683-1689
15. American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2 (2004), American Thoracic Society, New York. http://www.thoracic.org/go/copd [updated 2005 September 8]
16. Yawn B.P., Mapel D.W., Mannino D.M., et al. Development of the lung function questionnaire (LFQ) to identify airflow obstruction. Int J COPD 5 (2010) 1-10
17. DeLong E.R., DeLong D.M., and Clarke Pearson D.L. Comparing the areas under two or more correlated receiver-operating characteristic curves; a nonparametric approach. Biometrics 44 (1988) 837-845
18. Kerlinger F.N. Foundations of behavioral research (1973), Holt, Rinehart and Winston, New York
19. Bednarek M., Maciejewski J., Wozniak M., et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 63 (2008) 402-407
20. Fromer L., and Cooper C.B. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. Int J Clin Pract 62 (2008) 1219-1236
21. Shahab L., Jarvis M.J., Britton J., et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 61 (2006) 1043-1047
22. Ware Jr. J.E., and Kosinski M. SF-36 health survey (version 2.0) (Technical Note, September 20) (1996), Health Assessment Lab, Boston
23. Nathan R.A., Sorkness C.A., Kosinski M., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
24. Schatz M., Sorkness C.A., Li J.T., et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 117 (2006) 549-556
25. Calverly P.M.A., Nordyke R.J., Halbert R.J., et al. Development of a population-based screening questionnaire for COPD. COPD: J Chron Obstruct Pulmon Dis 2 (2005) 225-232
26. Martinez R.J., Raczek A.E., Seifer F.D., et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD: J Chron Obstruct Pulmon Dis 5 (2008) 85-95
27. Buffels J., Degryse J., Heyrman J., et al. Office spirometry significantly improves early detection of COPD in general practice. The DIDASCO study. Chest 125 (2004) 1394-1399
28. Beeh K.M., Kornmann O., Beier J., et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 98 (2004) 591-597
29. Price D., Tinkelman D., Nordyke R., et al. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 129 (2006) 1531-1539
30. van Schayck C., Loozen J., Wagena E., et al. Detecting patients at high risk of developing chronic obstructive pulmonary disease in a general practice: cross sectional case finding study. BMJ 324 (2002) 1370
31. Mullerova H., Wedzicha J., Soriano J., et al. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med 98 (2004) 78-83
32. Barr R., Herbstman J., Speizer F., et al. Validation of a self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 155 (2002) 965-971
33. Price D.B., Tinkelman D.G., Halbert R.J., et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 73 (2006) 285-295
34. Kida K, Wakabayashi R, Mizuuchi T, et al. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). doi:10.2169/internalmedicine.45.1694.
35. Freeman D., Nordyke R.J., Isonaka S., et al. Questions for COPD diagnostic screening in a primary care setting. Respir Med 99 (2005) 1311-1318